Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italia
about
Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphomaRecent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomasFollicular lymphoma: 2014 update on diagnosis and managementClinical considerations for biosimilar antibodies.Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma.Nature and importance of follicular lymphoma precursors.Follicular Lymphoma: The Management of Elderly Patient.How we manage follicular lymphoma.Therapeutic approaches in patients with newly diagnosed follicular lymphoma.Biosimilar monoclonal antibodies in lymphoma: a critical appraisal.A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas.Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma.Is there a role for a maintenance rituximab in indolent lymphoproliferative diseases other than follicular lymphoma?High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.Follicular lymphoma: 2015 update on diagnosis and management.Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database.Rituximab maintenance therapy in diffuse large B-cell lymphoma: is XY the most important variable?Follicular lymphoma: 2018 update on diagnosis and management.Title: Rituximab: A Benchmark in the Development of Chemotherapy-free Treatment Strategies for Follicular Lymphomas.Unmet needs in the first-line treatment of follicular lymphoma.Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P2860
Q26775837-824CB462-8F06-47CF-99D5-6C61EF12C9B4Q26784108-37C185CD-2126-4A9E-BEA0-AB5E4EB35835Q27021850-0798FA57-3170-4A99-824C-00377C4FD960Q30377239-EE9E0715-18C0-409F-84CB-E66739F6254AQ33415469-005FAF1A-F52C-4EAD-A99E-61BAEEAE7C8BQ33558757-F0BF7717-27FA-4EA0-B403-61C24F0D2B21Q37577856-8EFC3421-7EE1-40C1-B8E8-C344A2A3ECDDQ38191811-1C03394E-57B9-4572-815F-0BB45CDA9CAEQ38267041-66651C92-CDE2-4FBE-9487-DF0DD6E129BFQ38394272-EE620006-E2C2-401A-B85A-61C037E1E2A4Q38465823-825A8C04-5474-4C1E-BCEA-5CF1438975BCQ38568358-6FCFA525-1674-46EB-800A-E4C8AB86A788Q38781996-B6686930-BAAE-4F62-8E99-54C5AC051676Q39215476-9DC23563-60FB-4C5E-AAB9-955F072A4B7FQ40063998-FBCBE95F-209D-4428-BD77-A97C607FFC07Q40122693-4CD5B5CA-3A27-4294-B9A9-E83DD7102646Q41465999-E220F7E7-76D7-48D4-AC92-82CF0569D329Q42384627-FDDC5E67-5488-45E6-8D5D-82323622A236Q47219215-C625D5CB-E64B-4A8E-8B47-A257FD6B4B74Q47365893-2CA1E5B4-BC7D-4B28-B866-ED9098E84151Q50710717-40CA34EC-FEA7-4D25-B961-97857C5FFFDCQ59273877-FBD5566F-0FFC-4334-AA2B-A87F4BE17C97
P2860
Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italia
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Rituximab maintenance compared ...... study by the Fondazione Italia
@en
Rituximab maintenance compared ...... study by the Fondazione Italia
@nl
type
label
Rituximab maintenance compared ...... study by the Fondazione Italia
@en
Rituximab maintenance compared ...... study by the Fondazione Italia
@nl
prefLabel
Rituximab maintenance compared ...... study by the Fondazione Italia
@en
Rituximab maintenance compared ...... study by the Fondazione Italia
@nl
P2093
P50
P356
P1476
Rituximab maintenance compared ...... he Fondazione Italiana Linfomi
@en
P2093
Alessandra Tucci
Alessia Bari
Amalia De Renzo
Andrea Evangelista
Antonello Pinto
Barbara Botto
Carola Boccomini
Chiara Lobetti-Bodoni
Claudia Castellino
Enrica Gamba
P304
P356
10.1200/JCO.2012.44.8290
P407
P50
P577
2013-08-19T00:00:00Z